Glenmark Pharmaceuticals Sees Surge in Open Interest Amid Ongoing Market Challenges
Glenmark Pharmaceuticals Ltd. has seen a notable rise in open interest, reaching 37,004 contracts, alongside a trading volume of 57,156 contracts. Despite this increased trading activity, the stock has underperformed, declining by 3.05% today and trading below key moving averages, indicating ongoing market challenges.
Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting notable activity in its trading. The latest open interest stands at 37,004 contracts, up from the previous 33,078, marking a change of 3,926 contracts or an 11.87% increase. The trading volume for the day reached 57,156 contracts, indicating robust engagement in the market.Despite this uptick in open interest, Glenmark's stock has underperformed relative to its sector, declining by 3.05% today. The stock opened lower, with a gap down of 3.53%, and reached an intraday low of Rs 1,370. Over the past three days, the stock has seen a cumulative decline of 4.16%. Additionally, Glenmark is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend.
The company's market capitalization is approximately Rs 40,085 crore, placing it within the large-cap category in the Pharmaceuticals and Biotechnology industry. Overall, while the increase in open interest may indicate heightened trading activity, the stock's recent performance reflects ongoing challenges in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
